POMDOCTOR Ltd
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
▼ -98.9% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| ADVBAdvanced Biomed Inc. | $9.70 | 2.4x | 1.5x | — | 71.33% | $16.03M |
| ALTAltimmune, Inc. | $3.19 | — | 1.3x | — | -28.88% | $620.51M |
| BIIBBiogen Inc | $228.69 | 40.7x | 1.8x | — | 4.58% | $33.79B |
| CBIOCrescent Biopharma Inc | $17.75 |
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.
Company description provided by Yahoo Finance.
| — |
| 3.7x |
| — |
| — |
| $659.36M |
| CLDXCelldex Therapeutics, Inc. | $31.12 | — | 3.4x | — | -43.88% | $2.44B |
| CNTNCanton Strategic Holdings, Inc. | $2.69 | — | 0.5x | — | -42.21% | $214.34M |